Cargando…
Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics
Over the past several decades, nanocarriers have demonstrated diagnostic and therapeutic (i.e., theranostic) potencies in translational oncology, and some agents have been further translated into clinical trials. However, the practical application of nanoparticle-based medicine in living organisms i...
Autores principales: | Gareev, Kamil, Tagaeva, Ruslana, Bobkov, Danila, Yudintceva, Natalia, Goncharova, Daria, Combs, Stephanie E., Ten, Artem, Samochernych, Konstantin, Shevtsov, Maxim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096980/ https://www.ncbi.nlm.nih.gov/pubmed/37049234 http://dx.doi.org/10.3390/nano13071140 |
Ejemplares similares
-
Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice
por: Yudintceva, Natalia, et al.
Publicado: (2022) -
A new look at Hsp70 activity in phosphatidylserine-enriched membranes: chaperone-induced quasi-interdigitated lipid phase
por: Tagaeva, Ruslana, et al.
Publicado: (2023) -
Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
por: Yudintceva, Natalia, et al.
Publicado: (2021) -
Editorial: Radiotheranostics: From basic research to clinical application
por: Gareev, Kamil G., et al.
Publicado: (2023) -
Editorial: Functionalized Nanocarriers for Theranostics
por: Leporatti, Stefano, et al.
Publicado: (2020)